Genetics of Viral Entry and Host Susceptibility

Viral entry into host cells depends on receptor availability and protease activation. Genetic variants in ACE2, TMPRSS2, and related genes affect SARS-CoV-2 entry efficiency and may influence COVID-19 susceptibility, severity, and post-infection outcomes.

This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.

What is Viral Entry and Host Susceptibility?

SARS-CoV-2 enters host cells via the ACE2 receptor, which is primed by TMPRSS2 (transmembrane protease serine 2). Furin cleavage at the S1/S2 junction of the spike protein is also required. Genetic variation in ACE2 expression levels and coding sequences may modulate receptor binding affinity. TMPRSS2 variants affecting protease activity influence viral priming efficiency. NRP1 (neuropilin-1) acts as a co-receptor enhancing viral entry. Basigin (BSG/CD147) has been proposed as an alternative receptor. Genetic determinants of viral entry efficiency may contribute to individual variation in COVID-19 susceptibility and severity.

Biological pathways commonly discussed in relation to Viral Entry and Host Susceptibility

Research into SARS-CoV-2 Viral Entry and Host Receptor Genetics has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.

Ace2 Receptor

ACE2 is expressed on lung, heart, kidney, intestinal, and vascular cells. It is an angiotensin-converting enzyme that also cleaves SARS-CoV-2 spike protein with high affinity. ACE2 expression levels are regulated by sex hormones, inflammation, and genetic variation, influencing susceptibility.

Protease Priming

TMPRSS2 cleaves the spike protein at the S2 domain, enabling membrane fusion. TMPRSS2 variants affect protease activity. Camostat mesylate inhibits TMPRSS2, and TMPRSS2 genotype affects its efficacy as a potential antiviral.

Viral Attachment

SARS-CoV-2 spike RBD binds ACE2 with high affinity (~15 nM). Variants in the ACE2 extracellular domain could theoretically affect binding but no common coding variants with large effects have been identified. ACE2 expression level regulation is more impactful.

Host Cell Entry

Following receptor binding and protease priming, the spike fusion peptide inserts into the host cell membrane, driving membrane fusion and viral RNA delivery. NRP1 enhances entry efficiency in some cell types. IFITM proteins restrict early post-entry steps.

Key genes studied in relation to Viral Entry and Host Susceptibility

The following genes have been studied in relation to SARS-CoV-2 Viral Entry and Host Receptor Genetics. These genes span the biological pathways most commonly discussed in this area of research.

FURIN

FURIN encodes a proprotein convertase that cleaves at RXKR motifs; it activates SARS-CoV-2 spike at the S1/S2 furin cleavage site, a feature unique to SARS-CoV-2.

AR encodes the androgen receptor, mediating the effects of testosterone and DHT on gene expression in reproductive tissues and immune cells.

TMPRSS11D

TMPRSS11D encodes human airway trypsin-like protease (HAT), expressed in the trachea and bronchi, which can activate respiratory viruses.

TMPRSS4

TMPRSS4 is a type II transmembrane serine protease expressed in the gut and airway that can activate SARS-CoV-2 spike alongside TMPRSS2.

NRP2

NRP2 encodes neuropilin-2, which functions as a co-receptor for VEGF-C and semaphorins, and may facilitate SARS-CoV-2 entry in some cell types.

BSG

BSG encodes CD147/basigin, a multifunctional glycoprotein proposed as a co-receptor for SARS-CoV-2 spike binding via the cyclophilin pathway.

PPIA

PPIA encodes cyclophilin A, a peptidyl-prolyl isomerase that facilitates protein folding and is implicated in CD147-mediated viral entry and inflammatory signaling.

SRD5A2

SRD5A2 encodes 5α-reductase type 2, which converts testosterone to the potent androgen DHT in the prostate and other tissues.

Genetic variants commonly discussed

The following genetic variants (SNPs) are found in genes that have been studied in relation to Viral Entry and Host Susceptibility. Each variant represents a position in the genome where individuals may carry different alleles.

rs4702FURIN rs17514846FURIN rs2521501FURIN rs9332964AR rs6152AR rs66766036AR

13 variants total across genes studied in relation to Viral Entry and Host Susceptibility.

How personal DNA data may provide educational insights

Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as Viral Entry and Host Susceptibility.

This is not a diagnostic service. Genetic variants do not determine whether you have Viral Entry and Host Susceptibility, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.

Related conditions and pathways

Viral Entry and Host Susceptibility shares biological pathways and genetic associations with the following related conditions and areas of research.

Immune Dysregulation Long Covid Interferon Response Inflammation Antiviral Response

Frequently asked questions

How do ACE2 genetics affect COVID-19 susceptibility?

ACE2 expression levels — regulated by promoter variants, sex hormones, and inflammatory signals — may influence COVID-19 susceptibility. Higher ACE2 expression provides more binding sites for SARS-CoV-2 but also mediates protective angiotensin metabolism. The relationship is complex and bidirectional.

What is TMPRSS2 and why is it relevant to COVID-19?

TMPRSS2 is a serine protease that cleaves the SARS-CoV-2 spike protein, enabling efficient viral entry via membrane fusion. TMPRSS2 was initially of interest because it is androgen-regulated (linked to higher male COVID-19 severity) and because TMPRSS2 inhibitors were proposed as antivirals. Genetic variants affecting its activity may modulate viral entry efficiency.

What is the O blood type COVID-19 connection?

ABO blood type (gene ABO) showed an association with COVID-19 susceptibility in GWAS studies — O blood type appears modestly protective and A blood type slightly increases risk. Proposed mechanisms include blood group antigens on ACE2 affecting viral attachment, and anti-A antibodies in O-type individuals neutralising virus.

Which viral entry genes are studied?

Key genes include ACE2, TMPRSS2, FURIN, NRP1, ABO, IFITM3, and BSG. Together these cover receptor availability, protease activation, co-receptor function, and host restriction factors.

Long COVID Genetic Testing: What Your DNA Can Show
Can long COVID genetic testing help? Learn what consumer DNA tests can and cannot reveal, and how raw data links to viral entry and interferon genes.
Long COVID Genetics: What Host DNA Research Suggests
A plain-English guide to long COVID genetics: how genes for viral entry, interferon signaling and immune clearance may shape risk and recovery.
Why Does Long COVID Happen? Causes and Genetics
Why does Long COVID happen? Explore leading theories, from viral persistence to microclots, and how genes like ACE2 and IFNL3 may play a role.

Explore DNA insights

If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to Viral Entry and Host Susceptibility and connected biological pathways.

Get Your Personalised DNA Report

Informational and educational only · Not a diagnostic tool · GDPR compliant

8 genes · 13 variants analysed in relation to Viral Entry and Host Susceptibility